Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tg Therapeuticscmn
(NQ:
TGTX
)
16.19
-0.23 (-1.40%)
Official Closing Price
Updated: 4:15 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tg Therapeuticscmn
< Previous
1
2
3
4
5
6
7
8
9
Next >
21 Stocks Moving in Monday's Pre-Market Session
April 18, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) shares rose 16.2% to $2.51 in pre-market trading. Mullen Automotive announced plans to begin construction for EV battery pack...
Via
Benzinga
TG Therapeutics Retracts FDA Request For Ublituximab / Ukoniq Combo In Blood Cancers
April 18, 2022
Via
Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
TG Therapeutics: Q4 Earnings Insights
March 01, 2022
TG Therapeutics (NASDAQ:TGTX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold On Blood Cancer Trials
January 27, 2022
TG Therapeutics Inc's (NASDAQ: TGTX) CEO Michael Weiss said that the FDA has
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...
Via
Benzinga
TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Alert: Investigation over Potential Wrongdoing
March 23, 2022
San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Certain directors of TG Therapeutics, Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Looking Into TG Therapeutics's Return On Capital Employed
March 04, 2022
TG Therapeutics (NASDAQ:TGTX) brought in sales totaling $2.32 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.99%, resulting in a loss...
Via
Benzinga
FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings
March 03, 2022
The FDA has extended the review period of TG Therapeutics Inc's (NASDAQ: TGTX) biologics license application and supplemental New Drug Application for...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
March 02, 2022
The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios...
Via
Benzinga
Where TG Therapeutics Stands With Analysts
January 24, 2022
Within the last quarter, TG Therapeutics (NASDAQ:TGTX) has observed the fol...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028
February 03, 2022
Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,...
Via
FinancialNewsMedia
Exposures
COVID-19
Massive Month-End Buying of Biggest Losers
January 31, 2022
The average stock in the Russell 3,000 is now up 7% from the index’s low point last Friday as we near the final close of January 2022.
Via
Talk Markets
64 Biggest Movers From Yesterday
January 28, 2022
Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:...
Via
Benzinga
52 Biggest Movers From Friday
January 31, 2022
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 27, 2022
Gainers Galapagos (NASDAQ:GLPG) stock rose 21.4% to $64.75 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.5 million, which is...
Via
Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...
Via
Benzinga
10 Biggest Price Target Changes For Monday
January 24, 2022
SVB Leerink cut Biogen Inc. (NASDAQ:BIIB) price ...
Via
Benzinga
TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Notice: Investigation over Possible Violations of Securities Laws
January 20, 2022
San Diego, CA -- (SBWIRE) -- 01/20/2022 -- TG Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
NASDAQ:TGTX Investor Notice: Investigation over Possible Securities Laws Violations by TG Therapeutics, Inc.
January 19, 2022
San Diego, CA -- (SBWIRE) -- 01/19/2022 -- An investigation was announced concerning potential securities laws violations by TG Therapeutics, Inc. in connection with certain financial statements.
Via
SBWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
Gainers SomaLogic (NASDAQ:SLGC) shares mo...
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
December 03, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
10 Biggest Price Target Changes For Wednesday
December 01, 2021
Morgan Stanley boosted Zscaler, Inc. (NASDAQ: ZS) price target from $275 to $330. Zscaler shares rose 7.1% to $371.50 in pre-market trading. Citigroup boosted Applied...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 30, 2021
Gainers Cumberland (NASDAQ:CPIX) stock...
Via
Benzinga
Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher
November 30, 2021
Toward the end of trading Tuesday, the Dow traded down 1.44% to 34,628.69 while the NASDAQ fell 1.34% to 15,571.16. The S&P also fell, dropping 1.36% to 4,592.03. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
52 Biggest Movers From Yesterday
December 01, 2021
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.